Prolyl hydroxylase domain inhibitors: a new era in the management of renal anemia

Ann Transl Med. 2019 Dec;7(Suppl 8):S334. doi: 10.21037/atm.2019.09.118.

Authors

Yu Kurata¹, Tetsuhiro Tanaka¹, Masaomi Nangaku¹

Affiliation

¹ Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.

No abstract available

Publication types

Editorial
Comment